These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 31305125)
1. Association between CA repeat polymorphism in IGF1 gene promoter and colorectal cancer risk in a native Chinese population. Chao XL; Wang LL; Liu R; Li Y; Zhou XJ Neoplasma; 2019 Nov; 66(6):1002-1008. PubMed ID: 31305125 [TBL] [Abstract][Full Text] [Related]
2. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. Zecevic M; Amos CI; Gu X; Campos IM; Jones JS; Lynch PM; Rodriguez-Bigas MA; Frazier ML J Natl Cancer Inst; 2006 Jan; 98(2):139-43. PubMed ID: 16418517 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer. Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946 [TBL] [Abstract][Full Text] [Related]
4. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723 [TBL] [Abstract][Full Text] [Related]
5. IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer. Reeves SG; Rich D; Meldrum CJ; Colyvas K; Kurzawski G; Suchy J; Lubinski J; Scott RJ Int J Cancer; 2008 Sep; 123(6):1339-43. PubMed ID: 18623088 [TBL] [Abstract][Full Text] [Related]
6. A microsatellite polymorphism in IGF1 gene promoter and timing of natural menopause in Caucasian women. Kaczmarek M; Pacholska-Bogalska J; Kwaśniewski W; Kotarski J; Halerz-Nowakowska B; Goździka-Józefiak A Int J Med Sci; 2015; 12(1):32-41. PubMed ID: 25552916 [TBL] [Abstract][Full Text] [Related]
7. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese. Wong HL; Delellis K; Probst-Hensch N; Koh WP; Van Den Berg D; Lee HP; Yu MC; Ingles SA Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):144-51. PubMed ID: 15668488 [TBL] [Abstract][Full Text] [Related]
8. Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly. Sala E; Filopanti M; Ferrante E; Barbieri AM; Malchiodi E; Verrua E; Giavoli C; Lania AG; Arosio M; Beck-Peccoz P; Spada A; Mantovani G Eur J Clin Invest; 2014 Dec; 44(12):1222-9. PubMed ID: 25370837 [TBL] [Abstract][Full Text] [Related]
9. Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study. Simons CC; Schouten LJ; Godschalk RW; van Engeland M; van den Brandt PA; van Schooten FJ; Weijenberg MP Int J Cancer; 2017 Jan; 140(2):272-284. PubMed ID: 27649841 [TBL] [Abstract][Full Text] [Related]
10. The association of Li X; Yang J; Wang X; Gao X Nucleosides Nucleotides Nucleic Acids; 2022; 41(9):815-823. PubMed ID: 35634724 [TBL] [Abstract][Full Text] [Related]
11. Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study. Simons CC; Schouten LJ; Godschalk RW; van Engeland M; van den Brandt PA; van Schooten FJ; Weijenberg MP Sci Rep; 2015 Sep; 5():14126. PubMed ID: 26381944 [TBL] [Abstract][Full Text] [Related]
12. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055 [TBL] [Abstract][Full Text] [Related]
14. Interaction between CA repeat microsatellites and HIF1α regulated the transcriptional activity of porcine IGF1 promoter. Geng H; Hao L; Cheng Y; Wang C; Huang S; Wei W; Yang R; Li H; Liu S; Yu H; Lu H J Appl Genet; 2020 Feb; 61(1):105-112. PubMed ID: 31673965 [TBL] [Abstract][Full Text] [Related]
15. Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer. Kwasniewski W; Gozdzicka-Jozefiak A; Wolun-Cholewa M; Polak G; Sierocinska-Sawa J; Kwasniewska A; Kotarski J Mol Med Rep; 2016 Jun; 13(6):4950-8. PubMed ID: 27121258 [TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk. de Kort S; Simons CCJM; van den Brandt PA; Janssen-Heijnen MLG; Sanduleanu S; Masclee AAM; Weijenberg MP Int J Cancer; 2019 Oct; 145(7):1774-1781. PubMed ID: 31018241 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency. Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of insulin-like growth factor-1 CA repeat polymorphism on breast cancer risk along with race: a meta-analysis. He B; Xu Y; Pan Y; Li R; Gao T; Song G; Gu L; Nie Z; Chen L; Wang S Gene; 2013 Aug; 525(1):92-8. PubMed ID: 23628798 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study. Banday MZ; Sameer AS; Chowdri NA; Haq E Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach. Wong HL; Koh WP; Probst-Hensch NM; Van den Berg D; Yu MC; Ingles SA Gut; 2008 Aug; 57(8):1090-6. PubMed ID: 18308828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]